Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Metadata
Title
Time-Domain Evaluation of Cyclosporine Interaction with Hemodynamic Variability in Rats
Authors
Amal G. Omar
Mahmoud M. El-Mas, Ph.D.
Publication date
01-11-2004
Publisher
Kluwer Academic Publishers
Published in
Cardiovascular Drugs and Therapy / Issue 6/2004
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-004-6223-1

Other articles of this Issue 6/2004

Cardiovascular Drugs and Therapy 6/2004 Go to the issue

Letter to the Editor

BNP and Functional Status in Heart Failure (Response)

Letter to the Editor

BNP and Functional Status in Heart Failure

Basic Pharmacology

Sertraline Causes Strong Coronary Vasodilation: Possible Relevance for Cardioprotection by Selective Serotonin Reuptake Inhibitors

Basic Pharmacology

N-2-mercaptopropionylglycine, a Scavanger of Reactive Oxygen Species, does not Modify the Early Antiarrhythmic Effect of Ischaemic Preconditioning in Anaesthetised Dogs

Review Article

New Pharmacological Strategies in Chronic Heart Failure

Pharmaco-Economics and Pharmaco-Epidemiology

A Novel Data Mining Approach to the Identification of Effective Drugs or Combinations for Targeted Endpoints—Application to Chronic Heart Failure as a New Form of Evidence-based Medicine

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits